Tom Salemi
John R. Adler, director of radiosurgery and stereotactic surgery at Stanford School of Medicine, raised a few eyebrows during his...
Ortho Dx: Where Does It Hurt?
Lost in the rush to develop better implants and devices to treat orthopedic injury is the need for better diagnostics capable of pinpointing injury and foretelling the onset of disease. A group of companies is working on just that.
More from Archive
More from In Vivo
• By
Jana Grieb, European regulatory and market access legal expert at McDermott Will & Emery, explains why the healthtech and pharma industries are warming to the new EU health commissioner as he faces calls to make the MDR more “user friendly.”
• By
While big pharma pours billions into creating new anti-aging molecules, a Belgian startup has taken a different path: combining existing safe drugs with AI precision. The early results suggest it might be onto something revolutionary.
• By
Bristol Myers Squibb executive Doxie Jordan discusses his path to global commercial leadership and the principles guiding pharmaceutical market strategy